Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Galgeunhaegi-tang (GHT) is a traditional Korean herbal medicine formula prescribed within Sasang constitutional medicine for the Taeeumin (TE) body type, specifically to treat Interior Heat patterns. The formula is a multi-herb decoction typically containing *Pueraria lobata* (Galgeun), *Scutellaria baicalensis*, *Ligusticum tenuissimum* (Gobon), *Platycodon grandiflorum*, and *Angelica dahurica*, among others. It is designed to resolve heat depression (鬱熱) and accompanying dryness (燥). Clinical and preclinical research has explored its potential in inhibiting tumor progression in non-small cell lung cancer (NSCLC), managing trigeminal neuralgia, and modulating immune responses. As a botanical preparation, it exerts multi-target effects, including anti-inflammatory and antioxidant activities, and is commonly administered as an oral decoction or in granule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on galgeunhaegi-tang.